VeriMomsodium caproamphoacetate est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classifications (no H360/H361) and no SCCS/CIR safety assessment indicating reproductive hazard for sodium caproamphoacetate; peer‑reviewed reproductive/toxicology studies specific to this CAS are not reported. As an amphoteric surfactant used topically, systemic absorption is expected to be low but measurable for adults, so exposure is scored as 1 (low). Sources searched: ECHA C&L (no harmonised classification), PubChem, CosIng, PubMed (no reproductive studies found).
Related ingredients
Frequently asked questions
- sodium caproamphoacetate est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classifications (no H360/H361) and no SCCS/CIR safety assessment indicating reproductive hazard for sodium caproamphoacetate; peer‑reviewed reproductive/toxicology studies specific to this CAS are not reported. As an amphoteric surfactant used topically, systemic absorption is expected to be low but measurable for adults, so exposure is scored as 1 (low). Sources searched: ECHA C&L (no harmonised classification), PubChem, CosIng, PubMed (no reproductive studies found).
- sodium caproamphoacetate est-il sûr pendant l'allaitement ?
- No evidence of reproductive or lactation-specific toxicity and no harmonised classification; mechanism of reproductive/lactation toxicity not described in available databases. Low but measurable dermal exposure assumed for topical use (adult e=1). Sources: ECHA C&L, PubChem, CosIng, PubMed.
- sodium caproamphoacetate est-il sûr pour la peau de bébé ?
- No infant-specific toxicology or developmental data located and no regulatory flags for reproductive/developmental hazard. Because infant skin has higher absorption potential, the exposure score is increased by +1 compared with adults (adult e=1 → infant e=2). Typical use as a mild amphoteric surfactant supports low intrinsic hazard but higher relative exposure in 0–3 yr olds. Sources: CosIng, PubChem, ECHA C&L, PubMed (no infant studies found).
- Comment VeriMom évalue-t-il sodium caproamphoacetate ?
- VeriMom évalue sodium caproamphoacetate à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à sodium caproamphoacetate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à sodium caproamphoacetate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.